JP2014502347A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014502347A5 JP2014502347A5 JP2013537784A JP2013537784A JP2014502347A5 JP 2014502347 A5 JP2014502347 A5 JP 2014502347A5 JP 2013537784 A JP2013537784 A JP 2013537784A JP 2013537784 A JP2013537784 A JP 2013537784A JP 2014502347 A5 JP2014502347 A5 JP 2014502347A5
- Authority
- JP
- Japan
- Prior art keywords
- lateral flow
- flow immunoassay
- ic3b
- complement
- intact
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40929710P | 2010-11-02 | 2010-11-02 | |
| US61/409,297 | 2010-11-02 | ||
| PCT/US2011/058945 WO2012071145A1 (en) | 2010-11-02 | 2011-11-02 | Lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014502347A JP2014502347A (ja) | 2014-01-30 |
| JP2014502347A5 true JP2014502347A5 (enExample) | 2014-11-27 |
| JP5859557B2 JP5859557B2 (ja) | 2016-02-10 |
Family
ID=46146161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013537784A Active JP5859557B2 (ja) | 2010-11-02 | 2011-11-02 | 補体活性化についての側方流動イムノアッセイおよび補体関連障害のポイント・オブ・ケア評価のための使用法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US9182396B2 (enExample) |
| EP (2) | EP3095876A1 (enExample) |
| JP (1) | JP5859557B2 (enExample) |
| AU (2) | AU2011332241B2 (enExample) |
| CA (1) | CA2816423A1 (enExample) |
| ES (1) | ES2564290T3 (enExample) |
| MX (1) | MX340094B (enExample) |
| WO (1) | WO2012071145A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8865164B2 (en) * | 2010-11-02 | 2014-10-21 | Kypha, Inc. | Detecting complement activation |
| EP3095876A1 (en) | 2010-11-02 | 2016-11-23 | Kypha, Inc. | Point of care lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders |
| US9110030B2 (en) | 2012-06-29 | 2015-08-18 | Daniel A. Kerschensteiner | Colorimetric gelatinase assay |
| US9863944B2 (en) | 2013-06-10 | 2018-01-09 | Asahi Kasei Fibers Corporation | Immunochromatographic diagnosis kit |
| ES2842283T3 (es) * | 2014-05-02 | 2021-07-13 | Uab Research Foundation | Métodos y composiciones para el diagnóstico y tratamiento de la meningitis |
| US11029318B2 (en) * | 2015-08-28 | 2021-06-08 | Kypha, Inc. | Methods for predicting and treating patients with increased risk of adverse pregnancy outcome |
| KR102141591B1 (ko) * | 2016-05-13 | 2020-09-14 | 광주과학기술원 | 진단용 키트 |
| WO2019190877A1 (en) * | 2018-03-26 | 2019-10-03 | Alexion Pharmaceuticals, Inc. | High throughput method for measuring the protease activity of complement c3 convertase |
| EP3581934A1 (en) * | 2018-06-14 | 2019-12-18 | Otto-von-Guericke-Universität Magdeburg | Complement factors for diagnosis of low-grade infections in a human subject |
| WO2021222169A1 (en) * | 2020-04-27 | 2021-11-04 | Zinselmeyer Bernd H | Methods and systems for lateral flow immunoassay of various biological materials including sars-cov2 |
| EP4217744A4 (en) * | 2020-09-28 | 2024-11-06 | Allegheny Singer Research Institute | METHOD FOR DETERMINING A LEVEL OF A CELL FRAGMENT-BOUND COMPLEMENT ACTIVATION PRODUCT |
| EP4286850A4 (en) * | 2021-01-26 | 2024-11-27 | Sekisui Medical Co., Ltd. | IMMUNOLOGICAL ASSAY PROCEDURE |
| EP4334719A4 (en) * | 2021-05-07 | 2025-04-16 | Kypha, Inc. | TARGET MEASUREMENT |
| WO2023192436A1 (en) * | 2022-03-31 | 2023-10-05 | Alexion Pharmaceuticals, Inc. | Singleplex or multiplexed assay for complement markers in fresh biological samples |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5212071A (en) * | 1988-04-01 | 1993-05-18 | The Johns Hopkins University | Nucleic acids encoding a human C3b/C4b receptor (CR1) |
| JPS595958B2 (ja) | 1975-12-30 | 1984-02-08 | トウキヨウケイソウ カブシキガイシヤ | 変量測定・伝送装置 |
| EP0097440B1 (en) * | 1982-06-14 | 1986-09-24 | The Upjohn Company | Method and kit for removing and assaying complement system fragments |
| SE452067B (sv) * | 1986-04-11 | 1987-11-09 | Ulf R Nilsson | Reagens for och sett vid immunkemisk bestemning av c3a |
| SE452065B (sv) | 1986-04-11 | 1987-11-09 | Ulf R Nilsson | Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning |
| IL89790A (en) * | 1988-04-01 | 2002-05-23 | Johns Hopking University | Nucleic acid sequences that encode and cells that produce cr1 protein and methods of production and purification |
| US7371582B2 (en) * | 2002-01-23 | 2008-05-13 | Boditechmed Inc. | Lateral flow quantitative assay method and strip and laser-induced fluorescence detection device therefor |
| WO2004093636A2 (en) * | 2003-04-17 | 2004-11-04 | Rauno Joks | PLASMA C5a LEVELS AS AN INDICATOR OF ASTHMA SEVERITY |
| KR20060015646A (ko) | 2003-06-13 | 2006-02-17 | 유니버시티 오브 피츠버그 | 면역, 혈액 및 염증성 질환의 모니터링 방법 |
| ATE421093T1 (de) | 2003-09-29 | 2009-01-15 | Peas Inst Ab | Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten |
| US20050255533A1 (en) * | 2004-02-10 | 2005-11-17 | Brendan Bioscience, Llc | Comprehensive food allergy test |
| US20060292700A1 (en) * | 2005-06-22 | 2006-12-28 | Naishu Wang | Diffused interrupted lateral flow immunoassay device and method |
| WO2006124888A2 (en) | 2005-05-16 | 2006-11-23 | Brendan Bioscience, Llc | Detection of antigen specific immunocomplexes |
| US7910381B2 (en) | 2005-10-13 | 2011-03-22 | BioAssay Works | Immuno gold lateral flow assay |
| US8192742B2 (en) * | 2007-03-23 | 2012-06-05 | NovelMed Therapeutics | Method of inhibiting complement activation with human anti-factor C3 antibodies and use thereof |
| JP2012503170A (ja) * | 2008-07-15 | 2012-02-02 | ラピッド パトゲン スクリーニング，インク． | 側方流動イムノアッセイにおけるインサイツでの細胞の溶解 |
| CA2750155A1 (en) * | 2008-12-30 | 2010-07-08 | Centocor Ortho Biotech Inc. | Serum markers predicting clinical response to anti-tnf.alpha. antibodiesin patients with ankylosing spondylitis |
| US9291622B2 (en) * | 2009-05-21 | 2016-03-22 | Apellis Pharmaceuticals, Inc. | Complement assays and uses thereof |
| US8865164B2 (en) | 2010-11-02 | 2014-10-21 | Kypha, Inc. | Detecting complement activation |
| EP3095876A1 (en) | 2010-11-02 | 2016-11-23 | Kypha, Inc. | Point of care lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders |
-
2011
- 2011-11-02 EP EP15199549.5A patent/EP3095876A1/en not_active Withdrawn
- 2011-11-02 CA CA2816423A patent/CA2816423A1/en not_active Abandoned
- 2011-11-02 US US13/287,432 patent/US9182396B2/en active Active
- 2011-11-02 EP EP11842681.6A patent/EP2635702B1/en active Active
- 2011-11-02 ES ES11842681.6T patent/ES2564290T3/es active Active
- 2011-11-02 JP JP2013537784A patent/JP5859557B2/ja active Active
- 2011-11-02 WO PCT/US2011/058945 patent/WO2012071145A1/en not_active Ceased
- 2011-11-02 MX MX2013004960A patent/MX340094B/es active IP Right Grant
- 2011-11-02 AU AU2011332241A patent/AU2011332241B2/en active Active
-
2015
- 2015-08-13 US US14/825,437 patent/US9939446B2/en active Active
-
2016
- 2016-02-05 AU AU2016200772A patent/AU2016200772B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014502347A5 (enExample) | ||
| KR101939964B1 (ko) | 급성 신장 손상의 발견 또는 감시 방법, 장치 및 키트 | |
| US20110008804A1 (en) | Angiopoietin-1 and -2 biomarkers for infectious diseases that compromise endothelial integrity | |
| US9182396B2 (en) | Lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders | |
| US11041864B2 (en) | Method for prediction of prognosis of sepsis | |
| BRPI1007443B1 (pt) | método para diagnosticar nefropatia diabética em um indivíduo, método para avaliar a eficácia de um tratamento para nefropatia diabética em um indivíduo, método para determinação do estágio da nefropatia diabética em um indivíduo, método para monitoramento do progresso da nefropatia diabética em um indivíduo, e método para avaliar a eficácia de um tratamento para nefropatia diabética em um indivíduo | |
| JP2005106694A (ja) | 敗血症早期検出及び重篤度評価 | |
| AU2019240026B2 (en) | Biomarker combination for identification of "at-risk" subjects for AKI | |
| US10267807B2 (en) | Diagnosis and/or prognosis of renal dysfunction | |
| JP2010500535A5 (enExample) | ||
| JP5801895B2 (ja) | 全身性炎症反応症候群を伴わない術後感染症の検出方法 | |
| CN106461661A (zh) | 用于诊断和治疗脑膜炎的方法及组合物 | |
| US10094839B2 (en) | Biomarker of renal dysfunction | |
| WO2012093681A1 (ja) | 敗血症治療薬を投与する患者を選択する方法 | |
| US10371706B2 (en) | Biomarker of renal dysfunction | |
| Hanindita et al. | Neutrophil gelatinase-associated lipocalin as a biomarker for acute kidney injury in children after cardiac surgery | |
| JP2011232172A (ja) | βアミロイドに関連する病的状態の診断補助方法 | |
| Choi et al. | Research Article Significance of Neutrophil Gelatinase-Associated Lipocalin Level-to-Serum Creatinine Ratio for Assessing Severity of Inflammation in Patients with Renal Dysfunction | |
| EP3688469A1 (en) | Predictive biomarker ratio of aki |